Baidu
map

2019 AAC立场声明:膝关节骨关节炎关节内注射

2019-07-19 国外骨科相关专家小组(统称) Orthop J Sports Med. 2019 Jul 19;7(7):232596711986

2019年7月,加拿大关节镜协会(AAC)发布了膝关节骨关节炎关节内注射的立场声明,内容涉及糖皮质激素,透明质酸,富血小板血浆,骨髓浓缩物的注射以及联合治疗建议。

中文标题:

2019 AAC立场声明:膝关节骨关节炎关节内注射

英文标题:

Arthroscopy Association of Canada Position Statement on Intra-articular Injections for Knee Osteoarthritis.

发布日期:

2019-07-19

简要介绍:

2019年7月,加拿大关节镜协会(AAC)发布了膝关节骨关节炎关节内注射的立场声明,内容涉及糖皮质激素,透明质酸,富血小板血浆,骨髓浓缩物的注射以及联合治疗建议。

拓展指南:关节炎相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 AAC立场声明:膝关节骨关节炎关节内注射)] GetToolGuiderByIdResponse(projectId=1, id=792bd1c001e78618, title=2019 AAC立场声明:膝关节骨关节炎关节内注射, enTitle=Arthroscopy Association of Canada Position Statement on Intra-articular Injections for Knee Osteoarthritis., guiderFrom=Orthop J Sports Med. 2019 Jul 19;7(7):232596711986, authorId=null, author=, summary=2019年7月,加拿大关节镜协会(AAC)发布了膝关节骨关节炎关节内注射的立场声明,内容涉及糖皮质激素,透明质酸,富血小板血浆,骨髓浓缩物的注射以及联合治疗建议。 , cover=, journalId=null, articlesId=null, associationId=1089, associationName=国外骨科相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Fri Jul 19 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2019年7月,加拿大关节镜协会(AAC)发布了膝关节骨关节炎关节内注射的立场声明,内容涉及糖皮质激素,透明质酸,富血小板血浆,骨髓浓缩物的注射以及联合治疗建议。</P>拓展指南:<strong>与<font color=red>关节炎</font>相关指南:</strong><br><ul><li><a href="//m.sandwebs.com/guideline/show_article.do?id=793c21c001e607fe" title="2019 OARSI指南:膝关节、髋关节和多关节骨关节炎的非手术治疗" target=_blank>2019 OARSI指南:膝关节、髋关节和多关节骨关节炎的非手术治疗</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=20e0e1c001e3700e" title="2019 ACR/AF指南:幼年特发性关节炎相关性葡萄膜炎的筛查,监测和治疗" target=_blank>2019 ACR/AF指南:幼年特发性关节炎相关性葡萄膜炎的筛查,监测和治疗</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=39c961c001e3272f" title="膝骨关节炎阶梯治疗专家共识(2018 年版)" target=_blank>膝骨关节炎阶梯治疗专家共识(2018 年版)</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=056d11c001e133ef" title="2018 APLAR建议:中轴型脊柱关节炎的治疗" target=_blank>2018 APLAR建议:中轴型脊柱关节炎的治疗</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=bed7e1c001e12a8a" title="2018 APLAR建议:类风湿性关节炎的治疗(更新版)" target=_blank>2018 APLAR建议:类风湿性关节炎的治疗(更新版)</a></li> 更多信息请点击:<a href="//m.sandwebs.com/guideline/list.do?q=%E5%85%B3%E8%8A%82%E7%82%8E" target=_blank>有关关节炎更多指南</a></ul>, tagList=[TagDto(tagId=14324, tagName=膝关节骨关节炎), TagDto(tagId=93349, tagName=关节内注射)], categoryList=[CategoryDto(categoryId=10, categoryName=骨科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4996, appHits=328, showAppHits=8, pcHits=3116, showPcHits=2564, likes=98, shares=12, comments=15, approvalStatus=1, publishedTime=Tue Aug 13 21:42:39 CST 2019, publishedTimeString=2019-07-19, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Aug 13 21:42:39 CST 2019, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 23:30:53 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 AAC立场声明:膝关节骨关节炎关节内注射)])
2019 AAC立场声明:膝关节骨关节炎关节内注射
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2218119, encodeId=630d221811975, content=非常受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=001a8189382, createdName=ms3000001603080253, createdTime=Fri Aug 02 14:24:37 CST 2024, time=2024-08-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1215337, encodeId=9faf121533eee, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b76c8140620, createdName=ms6000001827485291, createdTime=Thu Apr 28 15:59:33 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976595, encodeId=ac7b9e65955d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/0922a5df24904e4f86d563d49079aa1d/bf4a0e7be5fb4e7892ff94a8306fe9b7.jpg, createdBy=fc9b4705948, createdName=麻无赦, createdTime=Thu Jun 24 19:59:29 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966715, encodeId=4fd0966e1561, content=非常适用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/31e7881efd8b467783f2ad8b87babdf6/4642e817f8c546a9b7c1001856e79bc2.jpg, createdBy=705b5502747, createdName=四海, createdTime=Wed May 19 00:07:48 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911734, encodeId=2d4e911e34e4, content=如何获取积分???, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23c71655529, createdName=polyetheretherketone, createdTime=Mon Dec 28 21:24:55 CST 2020, time=2020-12-28, status=1, ipAttribution=)]
    2024-08-02 ms3000001603080253 来自上海

    非常受用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2218119, encodeId=630d221811975, content=非常受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=001a8189382, createdName=ms3000001603080253, createdTime=Fri Aug 02 14:24:37 CST 2024, time=2024-08-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1215337, encodeId=9faf121533eee, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b76c8140620, createdName=ms6000001827485291, createdTime=Thu Apr 28 15:59:33 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976595, encodeId=ac7b9e65955d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/0922a5df24904e4f86d563d49079aa1d/bf4a0e7be5fb4e7892ff94a8306fe9b7.jpg, createdBy=fc9b4705948, createdName=麻无赦, createdTime=Thu Jun 24 19:59:29 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966715, encodeId=4fd0966e1561, content=非常适用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/31e7881efd8b467783f2ad8b87babdf6/4642e817f8c546a9b7c1001856e79bc2.jpg, createdBy=705b5502747, createdName=四海, createdTime=Wed May 19 00:07:48 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911734, encodeId=2d4e911e34e4, content=如何获取积分???, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23c71655529, createdName=polyetheretherketone, createdTime=Mon Dec 28 21:24:55 CST 2020, time=2020-12-28, status=1, ipAttribution=)]
    2022-04-28 ms6000001827485291

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2218119, encodeId=630d221811975, content=非常受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=001a8189382, createdName=ms3000001603080253, createdTime=Fri Aug 02 14:24:37 CST 2024, time=2024-08-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1215337, encodeId=9faf121533eee, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b76c8140620, createdName=ms6000001827485291, createdTime=Thu Apr 28 15:59:33 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976595, encodeId=ac7b9e65955d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/0922a5df24904e4f86d563d49079aa1d/bf4a0e7be5fb4e7892ff94a8306fe9b7.jpg, createdBy=fc9b4705948, createdName=麻无赦, createdTime=Thu Jun 24 19:59:29 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966715, encodeId=4fd0966e1561, content=非常适用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/31e7881efd8b467783f2ad8b87babdf6/4642e817f8c546a9b7c1001856e79bc2.jpg, createdBy=705b5502747, createdName=四海, createdTime=Wed May 19 00:07:48 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911734, encodeId=2d4e911e34e4, content=如何获取积分???, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23c71655529, createdName=polyetheretherketone, createdTime=Mon Dec 28 21:24:55 CST 2020, time=2020-12-28, status=1, ipAttribution=)]
    2021-06-24 麻无赦

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2218119, encodeId=630d221811975, content=非常受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=001a8189382, createdName=ms3000001603080253, createdTime=Fri Aug 02 14:24:37 CST 2024, time=2024-08-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1215337, encodeId=9faf121533eee, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b76c8140620, createdName=ms6000001827485291, createdTime=Thu Apr 28 15:59:33 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976595, encodeId=ac7b9e65955d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/0922a5df24904e4f86d563d49079aa1d/bf4a0e7be5fb4e7892ff94a8306fe9b7.jpg, createdBy=fc9b4705948, createdName=麻无赦, createdTime=Thu Jun 24 19:59:29 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966715, encodeId=4fd0966e1561, content=非常适用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/31e7881efd8b467783f2ad8b87babdf6/4642e817f8c546a9b7c1001856e79bc2.jpg, createdBy=705b5502747, createdName=四海, createdTime=Wed May 19 00:07:48 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911734, encodeId=2d4e911e34e4, content=如何获取积分???, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23c71655529, createdName=polyetheretherketone, createdTime=Mon Dec 28 21:24:55 CST 2020, time=2020-12-28, status=1, ipAttribution=)]
    2021-05-19 四海

    非常适用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2218119, encodeId=630d221811975, content=非常受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=001a8189382, createdName=ms3000001603080253, createdTime=Fri Aug 02 14:24:37 CST 2024, time=2024-08-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1215337, encodeId=9faf121533eee, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b76c8140620, createdName=ms6000001827485291, createdTime=Thu Apr 28 15:59:33 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976595, encodeId=ac7b9e65955d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/0922a5df24904e4f86d563d49079aa1d/bf4a0e7be5fb4e7892ff94a8306fe9b7.jpg, createdBy=fc9b4705948, createdName=麻无赦, createdTime=Thu Jun 24 19:59:29 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966715, encodeId=4fd0966e1561, content=非常适用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/31e7881efd8b467783f2ad8b87babdf6/4642e817f8c546a9b7c1001856e79bc2.jpg, createdBy=705b5502747, createdName=四海, createdTime=Wed May 19 00:07:48 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911734, encodeId=2d4e911e34e4, content=如何获取积分???, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23c71655529, createdName=polyetheretherketone, createdTime=Mon Dec 28 21:24:55 CST 2020, time=2020-12-28, status=1, ipAttribution=)]
    2020-12-28 polyetheretherketone

    如何获取积分???

    0

Baidu
map
Baidu
map
Baidu
map